March 2025
Paragon 28, an eminent company in the realm of medical devices, announced participation at the ACFAS Annual Scientific Conference. From March 27-29, this event is meant for exhibiting its new product innovations meant for better patient outcomes and improved surgical experiences. "It is an honor to engage with the premier foot and ankle specialists and bring them the latest innovations after an incredibly strong product launch cadence in 2024," according to CEO Albert DaCosta on the commitment of the company to continued innovation. Such strides and innovations set forth by Paragon 28 in the industry indicate their mission to keep up with the developments in patients' outcomes and experiences.
Paragon 28 will present its latest product, SMART 28℠ Case Management Portal, which integrates Artificial Intelligence-driven data analytics and 3D modeling to enhance surgical planning and execution. The portal offers a user-friendly interface for case scheduling, real-time engineer communication, and personalized surgical guides, a 12mm stem with advanced instrumentation added to the APEX 3D Total Ankle Replacement portfolio. The Phantom® Fibula Nail System is a minimally invasive implant to stabilize fibula fractures while minimizing soft tissue complications. The R3FLEX™ Stabilization System allows dynamic tension adjustment with real-time visualization during fixation. The FJ2000™ Power Console and Burr System are prepacked with sterile power for the various surgical procedures on the foot and ankle. The PRECISION® MIS Bunion System is a minimally invasive technique for tri-planar bunion correction to enhance precision during the surgery and promote a faster recovery for the patient.
Paragon 28 engages in interactive sessions for hands-on training and discussions related to recent advances in the foot and ankle surgery arena. This will include its very own Mobile Lab setup, a state-of-the-art mobile training lab, and an Innovations in Foot and Ankle Dinner, both aimed at educational and networking opportunities led by industry experts and Paragon 28 specialists. Paragon 28 emphasizes designing a patient-centric solution that aims to improve surgical consistency, decrease complication rates, and enhance procedural efficiency to ultimately enable surgeons to provide better patient care.
Under the PSLA of 1995, Paragon 28 mentions that details regarding the potential administration of foot and ankle patient care will weigh forward-looking statements. Such statements are based on current expectations and assumptions but are constantly affected by various risks and uncertainties. Therefore, undue reliance should not be put on them, and Paragon 28 does not intend to update these forward-looking statements.
March 2025
March 2025
March 2025
March 2025